These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12324506)

  • 1. Trimolecular complexes of lambda light chain dimers in serum of a patient with multiple myeloma.
    Abraham RS; Charlesworth MC; Owen BA; Benson LM; Katzmann JA; Reeder CB; Kyle RA
    Clin Chem; 2002 Oct; 48(10):1805-11. PubMed ID: 12324506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyclonal free light chain of Ig may interfere with interpretation of monoclonal free light chain κ/λ ratio.
    Levinson SS
    Ann Clin Lab Sci; 2010; 40(4):348-53. PubMed ID: 20947809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical profile of Bence-Jones type multiple myeloma.
    Lyubimova NV; Timofeev YS; Abaev VM; Votyakova OM; Osmanov EA; Kushlinskii NE
    Klin Lab Diagn; 2022 Oct; 67(10):570-574. PubMed ID: 36315171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FLC dimer with lambda type may false-migrate to the position of "albumin" band by urine protein electrophoresis on Sebia agarose gel-based detection system.
    Chen C; Chen P; Fang X
    J Clin Lab Anal; 2019 Feb; 33(2):e22658. PubMed ID: 30152095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic reference range of κ/λ free light chain ratio to screen for Bence Jones proteinuria is not significantly influenced by GFR.
    Schmidt-Hieltjes Y; Elshof C; Roovers L; Ruinemans-Koerts J
    Eur J Haematol; 2016 May; 96(5):527-31. PubMed ID: 26172558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strengths and weaknesses of methods for identifying monoclonal free light chains of Ig: examples from two cases with renal disease.
    Levinson SS
    Clin Chem Lab Med; 2016 Jun; 54(6):1039-43. PubMed ID: 26368046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma.
    Abraham RS; Clark RJ; Bryant SC; Lymp JF; Larson T; Kyle RA; Katzmann JA
    Clin Chem; 2002; 48(4):655-7. PubMed ID: 11901068
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of lambda type tetramer Bence-Jones proteinemia.
    Kozuru M; Benoki H; Sugimoto H; Sakai K; Ibayashi H
    Acta Haematol; 1977; 57(6):359-65. PubMed ID: 407767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies.
    Hill PG; Forsyth JM; Rai B; Mayne S
    Clin Chem; 2006 Sep; 52(9):1743-8. PubMed ID: 16858075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunoblotting procedure following agarose gel electrophoresis for detection of Bence Jones proteinuria compared with immunofixation and quantitative light chain determination.
    Withold W; Reinauer H
    Eur J Clin Chem Clin Biochem; 1995 Mar; 33(3):135-8. PubMed ID: 7605825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of monoclonal protein in 72 cases of multiple myeloma].
    Yang JJ; Zhang GS; Chen XR
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):152-4. PubMed ID: 12536652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turbidimetric measurement of Bence-Jones proteins using antibodies against free light chains of immunoglobulins. An artifact caused by different polymeric forms of light chains.
    Heino J; Rajamäki A; Irjala K
    Scand J Clin Lab Invest; 1984 Apr; 44(2):173-6. PubMed ID: 6426036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.
    Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT
    J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical spectrum of light chain myeloma. A study of 35 patients with special reference to the occurrence of amyloidosis.
    Stone MJ; Frendel EP
    Am J Med; 1975 May; 58(5):601-19. PubMed ID: 1130419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
    Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
    Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double spike in the electropherogram of a myeloma serum, from Bence Jones protein.
    Vladutiu AO; Kohli RK
    Clin Chem; 1977 Jan; 23(1):140-2. PubMed ID: 832364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
    Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
    Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of Serum Free Light Chains in Kappa and Lambda Lesions in Light-Chain Myelomas.
    Singh G
    Lab Med; 2019 Apr; 50(2):189-193. PubMed ID: 30423164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences identified between serum and urine immunofixation electrophoresis.
    Tracy E; Andrews DM; Constantin MA; Zhu Y
    Clin Chim Acta; 2015 Jan; 439():68-70. PubMed ID: 25307209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.
    Bradwell AR; Carr-Smith HD; Mead GP; Tang LX; Showell PJ; Drayson MT; Drew R
    Clin Chem; 2001 Apr; 47(4):673-80. PubMed ID: 11274017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.